Expert Insights On Fill/Finish
-
Demonstrating Non-Inferiority Of BFPCs Vs. Traditional Air Monitoring
7/22/2026
Demonstrating non-inferiority of bio-fluorescent particle counter (BFPC) technology to traditional active air-sampling methods is essential for implementation. Here's how to approach it.
-
Addressing The Particulate Challenge In Cell Therapy Products
7/15/2026
Cell therapy products challenge traditional particulate controls. One expert explains detection, mitigation, and contamination prevention.
-
An Open-Source Modeling Tool For Suspended Continuous Lyophilization
7/7/2026
Building on a continuous suspended-vial lyophilization workflow, process developers can model critical variables before doing physical experiments.
-
Why Dilution Gets Tricky: The Role Of Measurement Variability
5/5/2026
Dilution's effects on downstream processes and final formulation is often understated. A statistical framework can quantify measurement uncertainty's impacts.
-
Rethinking ATMP Assurance When Sterility Timelines, Reality Misalign
3/27/2026
The compendial 14-day sterility testing window exposes product and patient to numerous risks, but settling on a rapid alternative also presents its own set of challenges.
-
Organic Impurities: New Draft ICH Q3E Guidance For Leachables And Extractables
3/17/2026
A new draft guidance document from ICH, issued jointly with the EMA, adopts the position that the assessment of leachables and extractables requires a holistic framework for risk evaluation.
-
A Practical Look At Modern Downstream Processing For Biologics
2/25/2026
Part 2 in a series about current bioprocessing practices explores the latest in separation, purification, sterile filtration and aseptic filling.
-
Process Engineering's Key Role In Sterile Injectable Facility Design
2/24/2026
Quality requirements for parenteral drugs complicate facility design like few other regulated products. If you're developing injectables, be aware of these key issues.
-
A Novel In Vitro Glycosylation Approach For Difficult PTMs
2/19/2026
Post-translational modifications of membrane proteins have been historically challenging. Research shows how an in vitro approach brings stability and predictability.
-
A Peek Into Novo Nordisk's Sustainable Facility Construction Mindset
2/18/2026
Fill/finish operations are famously resource-heavy. Nonetheless, Novo set out to achieve ambitious environmental goals with its $4.1 billion project in North Carolina.